CN1438027A - Chinese medicine for treating breast disease - Google Patents
Chinese medicine for treating breast disease Download PDFInfo
- Publication number
- CN1438027A CN1438027A CN 03119681 CN03119681A CN1438027A CN 1438027 A CN1438027 A CN 1438027A CN 03119681 CN03119681 CN 03119681 CN 03119681 A CN03119681 A CN 03119681A CN 1438027 A CN1438027 A CN 1438027A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- preparation
- rhizoma
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a Chinese medicine for curing mamary aggregation. It is a compound Chinese medicine preparation made up by using 11 Chinese medicinal materials of prunella spike, ligusticum root, silkworm, turtle shell, bupleurum root, red peony root and others.
Description
Technical field:
The present invention relates to a kind of Chinese medicine for the treatment of nodules of the breast, particularly a kind of compound Chinese medicinal preparation of making by Chinese crude drugs such as Spica Prunellae, Rhizoma Chuanxiong, Bombyx Batryticatus, Carapax Trionycis, Radix Bupleuri, Radix Paeoniae Rubra, Flos Rosae Rugosae, Rhizoma Curcumae, Radix Angelicae Sinensis, Rhizoma Corydalis, Concha Ostreaes.
Background technology:
Development along with society, the change of people's dietary structure, cyclomastopathy is progressively ascendant trend, women's physical and mental health and safety in serious threat, accounted for first of women's malignant tumor in China's breast carcinoma, so excavate and study the new drug of treatment mastopathy, the mammary gland precancerosis is treated, be imperative work.The traditional Chinese medical science thinks that the main diseases that nodules of the breast takes place is because of being depressed emotion, and depression of liver-QI and then stagnation of QI expectorant coagulate, phlegm and blood stasis, and clinical symptoms is the Ruzhong caking, mastalgia from dialectical, is controlled suitable promoting flow of QI and blood, softening the hard mass, eliminating stagnation.At present, though the Chinese medicine of the treatment nodules of the breast of some listings is arranged, some belongs to cures the symptoms, not the disease, and some uses expensive composition, and some is cut and interrupt using owing to uncertain therapeutic efficacy in application process.
The invention provides a kind of determined curative effect, safe ready, little, the cheap pure traditional Chinese compound medicine of side effect.
Summary of the invention:
The invention provides a kind of Chinese medicine preparation of new treatment nodules of the breast, Chinese medicine of the present invention has the effect of promoting flow of QI and blood, hard masses softening and resolving, is used for mastalgia that syndrome of qi stagnation and blood stasis causes, lump in breast, dark etc. with nipple discharge, irritated irritability, fullness and distention in the chest and hypochondrium, the few color of menstrual blood volume.
Chinese medicine preparation of the present invention by Chinese crude drugs such as Spica Prunellae, Rhizoma Chuanxiong, Bombyx Batryticatus, Carapax Trionycis, Radix Bupleuri, Radix Paeoniae Rubra, Flos Rosae Rugosae, Rhizoma Curcumae, Radix Angelicae Sinensis, Rhizoma Corydalis, Concha Ostreaes through being processed into.
Chinese medicine preparation of the present invention, its prescription consists of: Spica Prunellae 148-594 part Rhizoma Chuanxiong 99-396 part Bombyx Batryticatus 59-238 part Carapax Trionycis 148-594 part Radix Bupleuri 99-396 part Radix Paeoniae Rubra 89-356 part Flos Rosae Rugosae 119-476 part Rhizoma Curcumae 89-356 part Radix Angelicae Sinensis 99-396 part Rhizoma Corydalis 89-356 part Concha Ostreae 148-594 part.
Spica Prunellae 222-396 part Rhizoma Chuanxiong 148-264 part Bombyx Batryticatus 89-158 part Carapax Trionycis 222-396 part Radix Bupleuri 148-264 part Radix Paeoniae Rubra 133-237 part Flos Rosae Rugosae 178-317 part Rhizoma Curcumae 133-237 part Radix Angelicae Sinensis 148-264 part Rhizoma Corydalis 133-237 part Concha Ostreae 222-396 part preferably.
More preferably 178 portions of Concha Ostreaes of 198 parts of Rhizoma Corydalis of 178 parts of Radix Angelicae Sinensis of 238 parts of Rhizoma Curcumae of 178 portions of Flos Rosae Rugosaes of 198 parts of Radix Paeoniae Rubra of 297 parts of Radix Bupleuri of 119 parts of Carapax Trionycis of 198 parts of Bombyx Batryticatus of 297 parts of Rhizoma Chuanxiongs of Spica Prunellae are 297 parts.
Chinese medicine preparation of the present invention can be prepared by following method:
More than ten simply, Bombyx Batryticatus is ground into fine powder, surplus medicated powder is broken into coarse powder.Get Carapax Trionycis, Concha Ostreae adds 4 times of water gagings, decocts 1 hour, and is standby; Spica Prunellae, Radix Bupleuri, Radix Paeoniae Rubra, Rhizoma Curcumae steam distillation extract volatile oil, medicinal residues and decocting liquid and Carapax Trionycis, the Concha Ostreae thing mixing and water adding that is decocted first decocts three times, is respectively collecting decoction 1.5 hours, 2.5 hours, 1.5 hours, centrifugal, the supernatant concentrating under reduced pressure becomes extractum; Rhizoma Chuanxiong, Flos Rosae Rugosae, Radix Angelicae Sinensis steam distillation extract volatile oil, and medicinal residues and decocting liquid and Rhizoma Corydalis merge, and adding ethanol adjustment concentration of alcohol is 70%, and the solvent total amount is 8 times of amounts of medical material.65 ℃ of warm macerating three times were respectively 1 hour, 2 hours, 0.5 hour, and immersion merges, and centrifugal, the supernatant decompression recycling ethanol also is condensed into extractum; Merge above-mentioned two kinds of extractum drying under reduced pressure, pulverize, add the Bombyx Batryticatus fine powder, mixing, spray adds volatile oil, and airtight placement obtains active constituents of medicine, and this active component is made Chinese medicine preparation of the present invention by the preparation technique of routine.
During more than prescription was formed, weight was calculated with crude drug, and as if being unit with the gram, this composition can be made into 1000 doses of pharmaceutical preparatioies, described 1000 doses of fingers, and the final drug preparation of making, as make 1000 of capsule preparations, 1000 in tablet, granule 1000g.
More than form, as if being unit with the gram, can be made into the preparation of 250 taking doses, as capsule, make 1000, each taking dose is 4, can take altogether 250 times.As granule, make 250 bags, take 1 bag at every turn, can take altogether 250 times.
More than form to be by weight as proportioning, when producing, can increase or reduce according to corresponding proportion, as large-scale production can be unit with the kilogram, or be unit with the ton, weight can increase or reduce, but the constant rate of the raw medicinal herbs weight proportion between each is formed should be in above-mentioned scope.Screening obtains the ratio of above weight proportion through science.
Chinese medicine preparation of the present invention, can add the medicine acceptable carrier when being prepared into medicament, described medicine acceptable carrier can be: starch, sucrose, lactose, mannitol, silicon derivative, cellulose and derivant thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, soil temperature 80, agar, calcium carbonate, calcium bicarbonate, surfactant, Polyethylene Glycol, cyclodextrin, beta-schardinger dextrin-, phospholipid material, Kaolin, Pulvis Talci, calcium stearate, magnesium stearate etc.
Chinese medicine preparation of the present invention can be any pharmaceutically useful dosage form, and these dosage forms comprise: tablet, sugar coated tablet, film coated tablet, enteric coated tablet, capsule, hard capsule, soft capsule, oral liquid, suck agent, granule, electuary, pill, powder, unguentum, sublimed preparation, suspensoid, powder, solution, injection, suppository, ointment, plaster, cream, spray, drop, patch.Preparation of the present invention, peroral dosage form preferably, as: capsule, tablet, oral liquid, granule, pill, powder, sublimed preparation, unguentum etc., more preferably capsule.
Preparation of the present invention is determined usage and dosage according to patient's situation in use, but obeys every day three times, each 1-4 agent, as: 1 bag or 4 or sheet.
Chinese medicine preparation of the present invention, be called " nodules of the breast eliminating stagnation capsule " at this, clinical trial through Dongzhimen Hospital, Beijing Univ of Traditional Chinese Medicine, The People's Hospital, the hospital of traditional Chinese hospital, Xi'an, Traditional Chinese Medicine Research Institute, Shanxi Province Affiliated Hospital to nodules of the breast eliminating stagnation capsule for treating cyclomastopathy (qi stagnation blood stasis type) 320 examples, 30 examples of fully recovering, produce effects 129 examples, total obvious effective rate 49.69%, total effective rate 91.88%, compare with matched group, curative effect between the two has the significance meaning, points out this medicine that curative effect is preferably arranged.
Nodules of the breast eliminating stagnation capsule is having significant difference with matched group aspect alleviation mastalgia and the lump in breast; Simultaneous phenomenon is improved the aspect therapeutical effect is preferably also arranged.To the mastalgia degree light, in, alleviate the situation there was no significant difference between heavy; Light to the state of an illness, in, heavy in various degree between the curative effect there was no significant difference, course of disease length removes＜half a year/1 year-, difference that each organizes that there are no significant, the cyclomastopathy of this medicine to the qi stagnation blood stasis type is described, state of an illness weight no matter, course of disease length, the pain degree weight all has certain curative effect.In treatment group and the matched group blood situation of change of estradiol and progestogen before treatment, treat back self relatively and relatively there are no significant between group difference, illustrate that this medicine and contrast medication all do not have obvious influence to the estrogen and progestogen level.Recovery from illness and produce effects case with in anti-, conservation rate is that 98.11% this medicine of explanation has late result preferably.In clinical observation, this medicine does not have serious adverse effects, and the slight malaise symptoms of 5 examples is arranged in 320 examples, all can alleviate after anti symptom treatment or drug withdrawal, illustrates that this medicine has applicability preferably.To the nearly half patient treat preceding, carried out blood, urine after treating, just routine, liver, renal function and Electrocardioscopy are all no abnormal, point out this medicine not have obvious toxic and side effects, clinical practice is safer.In a word, nodules of the breast eliminating stagnation capsule for treating cyclomastopathy (qi stagnation blood stasis type) through II clinical trial phase explanation effectively, safety, easily accepted by the patient, applicability is arranged.
Below experiment further specifies the beneficial effect of Chinese medicine preparation of the present invention, experiment drug use nodules of the breast eliminating stagnation capsule, and RUKUAIXIAO is used in contrast.
One, nodules of the breast eliminating stagnation capsule is to the therapeutic effect of cyclomastopathy
1, general form is learned the influence that changes:
Result's (table 1) is through ferrum and inspection statistics, and heavy dose of group of nodules of the breast eliminating stagnation capsule and RUKUAIXIAO group and saline control group compare, and the visible nodules of the breast eliminating stagnation capsule of significant difference (P＜0.01) can suppress the rabbit mammary gland enlargement that estrogen causes.
Table 1 nodules of the breast eliminating stagnation capsule increases the influence of degree to mammary gland
Mammary gland increases degree group n mammary gland sum
++++++-normal group 6001 23 24 control groups 6 12 741 24 Rupisanjie capsule 0.5g/kg 68673 24 Rupisanjie capsule 1.5g/kg 63597 24 contrast medicine 1.5g/kg 64686 24
2. to the influence of sex hormone level:
Result's (table 2) as seen, E in the blood
2With the P level, be starkly lower than saline control group (P＜0.05 and P＜0.01) in the heavy dose of treatment group of nodules of the breast eliminating stagnation capsule, RUKUAIXIAO does not then have this effect, and nodules of the breast eliminating stagnation capsule can reduce E
2With the level of P, thereby to resisting hyperplasia of mammary glands.
Table 4 nodules of the breast eliminating stagnation capsule is to influence (X ± S, n=6) the group E2 P PSH LH PRL of sex hormone level in the cyclomastopathy rabbit body
(pg/ml) (ng/ml) (Miu/ml) (Miu/ml) (ng/ml) normal group 54 ± 11 0.65 ± 0.16 1.49 ± 0.50 4.7 ± 2.0 2.69 ± 0.39 control group 71 ± 18 1.09 ± 0.12 2.40 ± 0.73 7.1 ± 2.2 3.76 ± 0.32 Rupisanjie capsule (0.5g/kg), 70 ± 10 0.70 ± 0.2 1.97 ± 0.89 5.1 ± 3.1 2.44 ± 0.48 Rupisanjie capsules (1.5g/kg), 53 ± 8*, 0.50 ± 0.06**, 1.57 ± 0.24 5.1 ± 0.4 2.09 ± 0.18 contrast medicines (1.5g/kg) 86 ± 20 1.20 ± 0.38 2.51 ± 0.42 7.6 ± 1.4 2.66 ± 0.19 and control group comparison: * P＜0.05 * * P＜0.01
Two, the capsular analgesic activity of nodules of the breast eliminating stagnation
1, mice hot plate method analgesic experiment
Select for use the burning pain threshold at 30s with 60 of interior female mices, be divided into 4 groups at random, 15 every group, give saline (negative control) respectively, RUKUAIXIAO (positive control), nodules of the breast eliminating stagnation capsule 1.5 and 4.5g/kg, more than respectively organize equal gastric infusion, the administration volume is 20ml/kg.With the burning pain threshold value that hot plate method (55 ± 0.5 ℃ of temperature) measures after the administration 0.5,1,2,4 respectively, 6h respectively organizes mice, allly surpass 60s person, all by 60s.Result's (table 3) shows, saline control group mice burning pain threshold value, and slightly fluctuation of test does not repeatedly have obvious statistics difference within 6h.Mice is once irritated stomach and gives nodules of the breast eliminating stagnation capsule, and its pain threshold increases.Show that nodules of the breast eliminating stagnation capsule has certain analgesia and has certain analgesic effect, and the persistent period is more of a specified duration, but onset is slower.
Table 3 nodules of the breast health is to the influence of mice burning pain threshold value
Burning pain threshold value (s, x ± s, n=15) group dosage
(g/kg) 0.5h 1h 2h 4h 6h salt solution group 24 ± 49 29 ± 10 26 ± 8 21 ± 9 31 ± 15 Rupisanjie capsule 1.5 23 ± 9 27 ± 12 32 ± 14 21 ± 11 34 ± 17 Rupisanjie capsules, 4.5 19 ± 6*, 35 ± 8*, 39 ± 11***, 31 ± 12**, 43 ± 14** contrast medicine, 4.5 33 ± 11**, 30 ± 14*, 37 ± 15**, 32 ± 17**, 41 ± 15*
Compare with the saline group in the same time: P＞0.05, * P＜0.05, * * * P＜0.01
2, Mus is turned round the body experiment
79 of Kunming mouses, female, body weight 21.3 ± 1.3g.Be divided into saline, pethidine 50mg/kg, RUKUAIXIAO 1.5g/kg, nodules of the breast eliminating stagnation capsule 0.5 1.5 and 4.5g/kg group at random.Test the previous day at the upper and lower noon and test and respectively be administered once in preceding 1 hour.Ip1% acetic acid 0.1ml/10g, mouse writhing number of times in 5-10 minute after the observation injection.Result's (table 4) as seen, saline control group mice writhing response occurs behind ip 1% acetic acid, the writhing response of pethidine group mice obviously reduces.Nodules of the breast eliminating stagnation capsule and lump in breast energy dissipating reduce the writhing response of mice, and prompting nodules of the breast eliminating stagnation capsule has certain analgesic activity.
Table 4 nodules of the breast eliminating stagnation capsule is to the influence of mouse writhing reaction
Group dosage (g/kg) n always turned round body number of times (X ± S) in 5 minutes
Saline group 13 22.5 ± 4.3
Pethidine 0.05 10 0.7 ± 0.8***
Nodules of the breast eliminating stagnation capsule 0.5 14 17.5 ± 7.0*
Nodules of the breast eliminating stagnation capsule 1.5 14 16.8 ± 8.7**
Nodules of the breast eliminating stagnation capsule 4.5 14 15.0 ± 7.2**
Contrast medicine 4.5 14 15.4 ± 5.6**
Compare with the saline group: * P＞0.05, * P＜0.05, * * * P＜0.01
Three, the capsular antiinflammatory action of nodules of the breast eliminating stagnation
1, the scorching method of caused by dimethylbenzene xylene
50 of mices, female, body weight 21.2 ± 1.5g is divided into 5 groups of saline, nodules of the breast eliminating stagnation capsule (0.5,1.5,4.5g/kg) and RUKUAIXIAO 4.5g/kg etc. at random.Test proxima luce (prox. luc) and cause scorching preceding 1h ig said medicine respectively, only be applied to left ear with dimethylbenzene 0.03ml/ and cause inflammation, auris dextra in contrast.Behind the 4h, take off neck and put to death animal, cut two ears, with 8mm punch out, inflammatory reaction such as edema.Nodules of the breast eliminating stagnation capsule 1.5～4.5g/kg irritates stomach, and significantly antiinflammatory action is arranged.
Table 5 nodules of the breast eliminating stagnation capsule to the influence of Mice Auricle inflammation (X ± S, n=10)
The heavy auris dextra method of double differences of group dosage left side ear value
(g/kg) (mg) (mg)
Saline group 24.5 ± 5.4 14.9 ± 3.3 9.6 ± 3.7
Nodules of the breast eliminating stagnation capsule 0.5 23.9 ± 4.1 15.1 ± 2.4 8.8 ± 3.4*
Nodules of the breast eliminating stagnation capsule 1.5 21.8 ± 4.3 15.0 ± 2.8 6.8 ± 1.9**
Nodules of the breast eliminating stagnation capsule 4.5 20.8 ± 2.3 14.5 ± 1.2 6.3 ± 1.8**
Contrast medicine 4.5 18.2 ± 3.0 13.1 ± 1.5 5.1 ± 2.2***
Compare with the saline group: * P＞0.05, * P＜0.05, * * * P＜0.01
2, subcutaneous cotton balls implantation
32 of SD rats, female, body weight 200.6 ± 32.5g is divided into saline, nodules of the breast eliminating stagnation capsule 1.5,4.5g/kg and RUKUAIXIAO 4.5g/kg group, 8 every group at random.Under the shallow fiber crops of urethane, it is subcutaneous that two sterilization cotton balls (each adds ampicillin 1mg for the about 30 ± 1mg/ of weight, autoclaving) are implanted rat both sides groin respectively, skin suture.The art proxima luce (prox. luc) begins the ig administration, and 1 time/day, continuous 10d.24h puts to death rat after the last administration, takes out granuloma induced by implantation of cotton pellets, and 60 ℃ of baking box oven dry are weighed, and deduct the raw cotton ball weight and form index as granuloma.
Result's (table 6) shows that this experimental model is made successfully, and implanting cotton balls weight obviously increases.Nodules of the breast health 1.5g/kg, 4.5g/kg do not have obvious influence (P＞0.05) to subcutaneous rat cotton balls implantation granuloma, but the granulomatous trend of inhibition is arranged.
Table 6 nodules of the breast eliminating stagnation capsule is to the granulomatous influence of subcutaneous rat (X ± S)
Group dosage (g/kg) granuloma net weight (mg/100g body weight)
Saline group 43.7 ± 6.4
Nodules of the breast eliminating stagnation capsule 1.5 43.3 ± 8.1*
Nodules of the breast eliminating stagnation capsule 4.5 41.0 ± 6.8*
Contrast medicine 4.5 38.3 ± 9.4*
* P＞0.05 of comparing with the saline group
The specific embodiment: further specify the present invention by the following examples
Embodiment 1
The preparation of capsule
Spica Prunellae 297g Rhizoma Chuanxiong (wine is processed) 198g Bombyx Batryticatus (parched with bran) 119g
Carapax Trionycis (vinegar system) 297g Radix Bupleuri (vinegar system) 198g Radix Paeoniae Rubra (wine stir-fry) 178g
Flos Rosae Rugosae 238g Rhizoma Curcumae (vinegar system) 178g Radix Angelicae Sinensis (wine is processed) 198g
Rhizoma Corydalis (vinegar system) 178g Concha Ostreae 297g
More than ten simply, Bombyx Batryticatus is ground into fine powder, surplus medicated powder is broken into coarse powder.Get Carapax Trionycis, Concha Ostreae adds 4 times of water gagings, decocts 1 hour, and is standby; Spica Prunellae, Radix Bupleuri, Radix Paeoniae Rubra, Rhizoma Curcumae steam distillation extract volatile oil, medicinal residues and decocting liquid and Carapax Trionycis, the Concha Ostreae thing mixing and water adding that is decocted first decocts three times, is respectively collecting decoction 1.5 hours, 2.5 hours, 1.5 hours, centrifugal, the supernatant concentrating under reduced pressure becomes extractum; Rhizoma Chuanxiong, Flos Rosae Rugosae, Radix Angelicae Sinensis steam distillation extract volatile oil, and medicinal residues and decocting liquid and Rhizoma Corydalis merge, and adding ethanol adjustment concentration of alcohol is 70%, and the solvent total amount is 8 times of amounts of medical material.650 ℃ of warm macerating three times were respectively 1 hour, 2 hours, 0.5 hour, and immersion merges, and centrifugal, the supernatant decompression recycling ethanol also is condensed into extractum; Merge above-mentioned two kinds of extractum drying under reduced pressure, pulverize, add the Bombyx Batryticatus fine powder, mixing adds an amount of 75% alcohol granulation, and drying is put coldly, and spray adds volatile oil, and airtight placement adds an amount of magnesium stearate, and is encapsulated, makes 1000, promptly.
Embodiment 2
The preparation of tablet
Spica Prunellae 297g Rhizoma Chuanxiong (wine is processed) 198g Bombyx Batryticatus (parched with bran) 119g
Carapax Trionycis (vinegar system) 297g Radix Bupleuri (vinegar system) 198g Radix Paeoniae Rubra (wine stir-fry) 178g
Flos Rosae Rugosae 238g Rhizoma Curcumae (vinegar system) 178g Radix Angelicae Sinensis (wine is processed) 198g
Rhizoma Corydalis (vinegar system) 178g Concha Ostreae 297g
More than ten simply, Bombyx Batryticatus is ground into fine powder, surplus medicated powder is broken into coarse powder.Get Carapax Trionycis, Concha Ostreae adds 4 times of water gagings, decocts 1 hour, and is standby; Spica Prunellae, Radix Bupleuri, Radix Paeoniae Rubra, Rhizoma Curcumae steam distillation extract volatile oil, medicinal residues and decocting liquid and Carapax Trionycis, the Concha Ostreae thing mixing and water adding that is decocted first decocts three times, is respectively collecting decoction 1.5 hours, 2.5 hours, 1.5 hours, centrifugal, the supernatant concentrating under reduced pressure becomes extractum; Rhizoma Chuanxiong, Flos Rosae Rugosae, Radix Angelicae Sinensis steam distillation extract volatile oil, and medicinal residues and decocting liquid and Rhizoma Corydalis merge, and adding ethanol adjustment concentration of alcohol is 70%, and the solvent total amount is 8 times of amounts of medical material.65 ℃ of warm macerating three times were respectively 1 hour, 2 hours, 0.5 hour, and immersion merges, and centrifugal, the supernatant decompression recycling ethanol also is condensed into extractum; Merge above-mentioned two kinds of extractum drying under reduced pressure, pulverize, add the Bombyx Batryticatus fine powder, mixing adds an amount of 75% alcohol granulation, and drying is put coldly, and spray adds volatile oil, and airtight placement adds an amount of magnesium stearate, and tabletting is made 1000, promptly.
Embodiment 3
The preparation of granule
Spica Prunellae 297g Rhizoma Chuanxiong (wine is processed) 198g Bombyx Batryticatus (parched with bran) 119g
Carapax Trionycis (vinegar system) 297g Radix Bupleuri (vinegar system) 198g Radix Paeoniae Rubra (wine stir-fry) 178g
Flos Rosae Rugosae 238g Rhizoma Curcumae (vinegar system) 178g Radix Angelicae Sinensis (wine is processed) 198g
Rhizoma Corydalis (vinegar system) 178g Concha Ostreae 297g
More than ten simply, Bombyx Batryticatus is ground into fine powder, surplus medicated powder is broken into coarse powder.Get Carapax Trionycis, Concha Ostreae adds 4 times of water gagings, decocts 1 hour, and is standby; Spica Prunellae, Radix Bupleuri, Radix Paeoniae Rubra, Rhizoma Curcumae steam distillation extract volatile oil, medicinal residues and decocting liquid and Carapax Trionycis, the Concha Ostreae thing mixing and water adding that is decocted first decocts three times, is respectively collecting decoction 1.5 hours, 2.5 hours, 1.5 hours, centrifugal, the supernatant concentrating under reduced pressure becomes extractum; Rhizoma Chuanxiong, Flos Rosae Rugosae, Radix Angelicae Sinensis steam distillation extract volatile oil, and medicinal residues and decocting liquid and Rhizoma Corydalis merge, and adding ethanol adjustment concentration of alcohol is 70%, and the solvent total amount is 8 times of amounts of medical material.65 ℃ of warm macerating three times were respectively 1 hour, 2 hours, 0.5 hour, and immersion merges, and centrifugal, the supernatant decompression recycling ethanol also is condensed into extractum; Merge above-mentioned two kinds of extractum drying under reduced pressure, pulverize, add the Bombyx Batryticatus fine powder, mixing adds an amount of 75% alcohol granulation, and drying is put coldly, and spray adds volatile oil, and airtight placement adds an amount of sucrose 80g, and ethanol 20ml granulates, and makes the 1000g granule, adorns 250 bags, promptly.
Claims (10)
1. a Chinese medicine preparation is characterized in that, is made by following Chinese medicine raw materials by weight proportion
Spica Prunellae 148-594 part Rhizoma Chuanxiong 99-396 part Bombyx Batryticatus 59-238 part
Carapax Trionycis 148-594 part Radix Bupleuri 99-396 part Radix Paeoniae Rubra 89-356 part
Flos Rosae Rugosae 119-476 part Rhizoma Curcumae 89-356 part Radix Angelicae Sinensis 99-396 part
Rhizoma Corydalis 89-356 part Concha Ostreae 148-594 part.
2. the Chinese medicine preparation of claim 1 is characterized in that, is made by following Chinese medicine raw materials by weight proportion
Spica Prunellae 222-396 part Rhizoma Chuanxiong 148-264 part Bombyx Batryticatus 89-158 part
Carapax Trionycis 222-396 part Radix Bupleuri 148-264 part Radix Paeoniae Rubra 133-237 part
Flos Rosae Rugosae 178-317 part Rhizoma Curcumae 133-237 part Radix Angelicae Sinensis 148-264 part
Rhizoma Corydalis 133-237 part Concha Ostreae 222-396 part.
3. the Chinese medicine preparation of claim 2 is characterized in that, is made by following Chinese medicine raw materials by weight proportion
119 parts of 198 parts of Bombyx Batryticatus of 297 parts of Rhizoma Chuanxiongs of Spica Prunellae
178 parts of 198 parts of Radix Paeoniae Rubra of 297 parts of Radix Bupleuri of Carapax Trionycis
198 parts of 178 parts of Radix Angelicae Sinensis of 238 parts of Rhizoma Curcumae of Flos Rosae Rugosae
297 parts of 178 portions of Concha Ostreaes of Rhizoma Corydalis.
4. the Chinese medicine preparation of claim 1-3 is to be fit to medicinal various dosage forms.
5. the Chinese medicine preparation of claim 4 is tablet, capsule, oral liquid, buccal tablet, granule, electuary, pill, powder, suspensoid, powder, solution, drop, drop pill.
6. the Chinese medicine preparation of claim 4 is capsules.
7. the Chinese medicine preparation of claim 1 prevents and/or treats application in the medicine of nodules of the breast in preparation.
8. the preparation method of the Chinese medicine preparation of claim 1 is characterized in that, may further comprise the steps:
A. Bombyx Batryticatus is ground into fine powder, and surplus medicated powder is broken into coarse powder;
B. get Carapax Trionycis, Concha Ostreae decocts with water standby;
C. Spica Prunellae, Radix Bupleuri, Radix Paeoniae Rubra, Rhizoma Curcumae steam distillation extract volatile oil, the thing mixing and water adding decoction of being decocted first of medicinal residues and decocting liquid and Carapax Trionycis, Concha Ostreae, and collecting decoction, centrifugal, the supernatant concentrating under reduced pressure becomes extractum;
D. Rhizoma Chuanxiong, Flos Rosae Rugosae, Radix Angelicae Sinensis steam distillation extract volatile oil, and medicinal residues and decocting liquid and Rhizoma Corydalis merge,
Add ethanol, warm macerating, immersion merges, and centrifugal, the supernatant decompression recycling ethanol also is condensed into extractum;
E. merge above-mentioned two kinds of extractum drying under reduced pressure, pulverize, add the Bombyx Batryticatus fine powder, mixing, drying, spray adds volatile oil, obtains active constituents of medicine;
F. this active component mixes with the medicine acceptable carrier.
9. the preparation method of claim 8 is characterized in that, decocting with water among the step c decocts three times altogether, each decocting time 1～3 hour.
10. the preparation method of claim 8 is characterized in that, adds the ethanol warm macerating in the steps d, and warm macerating is three times altogether, and each soak time is 0.5～2 hour.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031196810A CN1191849C (en) | 2003-03-20 | 2003-03-20 | Chinese medicine for treating breast disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031196810A CN1191849C (en) | 2003-03-20 | 2003-03-20 | Chinese medicine for treating breast disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1438027A true CN1438027A (en) | 2003-08-27 |
| CN1191849C CN1191849C (en) | 2005-03-09 |
Family
ID=27674234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031196810A Expired - Lifetime CN1191849C (en) | 2003-03-20 | 2003-03-20 | Chinese medicine for treating breast disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1191849C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101224290B (en) * | 2007-12-28 | 2010-07-14 | 李显成 | Chinese traditional medicine for treating breast nodules and preparing method thereof |
| CN102755515A (en) * | 2012-06-27 | 2012-10-31 | 蔡爱宁 | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands |
| CN104524201A (en) * | 2014-12-05 | 2015-04-22 | 青岛祥翔生物医药科技有限公司 | Traditional Chinese medicine for treating mammary nodule disease of liver-qi stagnation syndrome type |
| CN107440976A (en) * | 2017-09-23 | 2017-12-08 | 东莞市白天鹅纸业有限公司 | A kind of composition with whitening function and the hygenic towelette containing said composition |
| CN113995782A (en) * | 2021-12-07 | 2022-02-01 | 陕西白鹿制药股份有限公司 | Application of composition containing selfheal to preparation of medicine for treating thyroid nodules |
-
2003
- 2003-03-20 CN CNB031196810A patent/CN1191849C/en not_active Expired - Lifetime
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101224290B (en) * | 2007-12-28 | 2010-07-14 | 李显成 | Chinese traditional medicine for treating breast nodules and preparing method thereof |
| CN102755515A (en) * | 2012-06-27 | 2012-10-31 | 蔡爱宁 | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands |
| CN102755515B (en) * | 2012-06-27 | 2013-12-18 | 蔡爱宁 | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands |
| CN104524201A (en) * | 2014-12-05 | 2015-04-22 | 青岛祥翔生物医药科技有限公司 | Traditional Chinese medicine for treating mammary nodule disease of liver-qi stagnation syndrome type |
| CN107440976A (en) * | 2017-09-23 | 2017-12-08 | 东莞市白天鹅纸业有限公司 | A kind of composition with whitening function and the hygenic towelette containing said composition |
| CN113995782A (en) * | 2021-12-07 | 2022-02-01 | 陕西白鹿制药股份有限公司 | Application of composition containing selfheal to preparation of medicine for treating thyroid nodules |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1191849C (en) | 2005-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100342889C (en) | Chinese medicine for treating gout | |
| CN1907462A (en) | Traditional Chinese medicine composition for treating hepatitis and fatty liver | |
| CN1876074A (en) | A constipation-treating medicament and preparation method thereof | |
| CN1191849C (en) | Chinese medicine for treating breast disease | |
| CN1528386A (en) | Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof | |
| CN1151875A (en) | Chinese medicine prepn | |
| CN1709288A (en) | Medicinal composition, and its preparing method and use | |
| CN1872224A (en) | Composition of Chinese traditional medicine for treating rheumatism and preparation method | |
| CN1285354C (en) | Medicine for treating cerebral infarction | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN1748741A (en) | Little leaf deervetch herb acne removing preparation and new preparing method | |
| CN101032540A (en) | Medicine composition for curing arthritis and the preparing method and purpose thereof | |
| CN1899574A (en) | Chinese medicine composition for preventing and controlling liver cancer and its use | |
| CN1939480A (en) | Chinese-medicinal compound preparation for treating injury | |
| CN100339093C (en) | Compound medicine for treating coronary heart disease and angina pectoris and its preparing process | |
| CN1265810C (en) | A pharmaceutical composition for treating cyclomastopathy, and its preparation method | |
| CN1733197A (en) | Medicine for curing chronic prostatitis and process for preparing the same | |
| CN1304043C (en) | Longhedan pills and their preparation | |
| CN1340350A (en) | Chewing medicine for treating facial paralysis and its preparing process | |
| CN1634407A (en) | Chinese traditional medicine preparation for treating cholecystitis | |
| CN1296091C (en) | Chinese traditional medicine composition for treating psoriasis | |
| CN1446554A (en) | Medicine for treating acute cholecystitis and chronic cholecystitis and its preparing method | |
| CN1304027C (en) | Bone nourishing and rheumatic treating pills and their preparation | |
| CN1141113C (en) | Chinese patent medicine for curing peptic ulcer | |
| CN1123348C (en) | Capsule for treating rheumatic and rheumatoid arthritis and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20050309 |
|
| CX01 | Expiry of patent term |